中东和非洲炭疽病治疗市场报告 - 行业趋势和预测至2029年

中东和非洲炭疽病治疗市场，按类型（皮肤炭疽病、肺炭疽病和肠炭疽病）、给药途径（口服、肠外和其他）、最终用户（政府组织、医院、学术和研究机构等）行业趋势和预测到 2029 年。

中东和非洲炭疽病治疗市场

中东和非洲炭疽病治疗市场分析与洞察

中东和非洲炭疽病治疗市场受到多种因素的推动，例如细菌感染发病率上升、研究资金增加、炭疽病治疗新疗法的开发和管道产品增加了对炭疽病治疗的需求，以及研发投资的增加导致市场增长。目前，发达国家和新兴国家的医疗保健支出都有所增加，这有望为制造商开发新的创新产品创造竞争优势。

中东和非洲炭疽病治疗市场

全球患炭疽病的人数增加是推动炭疽病治疗市场增长的主要因素之一。研究人员为开发新型干预措施而获得的财政支持增加，以及平民和军队接触炭疽杆菌的威胁增加，加速了市场的增长。研发项目数量的增加，以及促进创新和有效治疗的新发展的公私伙伴关系的增加，进一步影响了市场。然而，治疗和程序的高成本以及政府对产品审批的严格规定预计将阻碍炭疽病治疗市场的增长。

中东和非洲炭疽病治疗市场报告提供了市场份额、新发展和产品线分析、国内和本地市场参与者的影响的详细信息，分析了新兴收入来源、市场法规变化、产品审批、战略决策、产品发布、地域扩张和市场技术创新方面的机会。要了解分析和市场情景，请联系我们获取分析师简报，我们的团队将帮助您创建收入影响解决方案，以实现您的预期目标。各地区发展中国家零售单位的可扩展性和业务扩展以及与供应商合作安全分销机器和药品是推动预测期内市场需求的主要驱动力。

中东和非洲炭疽病治疗市场具有支持性，旨在减缓疾病的进展。Data Bridge Market Research 分析称，在 2022 年至 2029 年的预测期内，中东和非洲炭疽病治疗市场的复合年增长率将达到 8.6%。

报告指标	细节
预测期	2022 至 2029 年
基准年	2021
历史岁月	2020（可定制至 2019 - 2014）
定量单位	收入（百万美元），定价（美元）
涵盖的领域	按类型（皮肤炭疽、肺炭疽和肠炭疽）、给药途径（口服、肠外和其他）、最终用户（政府组织、医院、学术和研究机构和其他）划分的行业趋势和预测（至 2029 年）
覆盖国家	沙特阿拉伯、南非、阿联酋、以色列、埃及、中东和非洲其他地区
涵盖的市场参与者	Alembic Pharmaceuticals、Sun Pharmaceutical Industries Ltd.、Zydus Group、Bayer AG、Pfizer Inc.、Lupin、Teva Pharmaceutical Industries Ltd.、ARISTO Pharmaceuticals Private Limited 等

中东和非洲炭疽病治疗市场动态

市场定义

炭疽病是由一种名为炭疽芽孢杆菌 (B. anthracis) 的细菌引起的。它主要是一种牲畜疾病，通过摄入土壤中的孢子而感染。人类通常通过接触受感染动物的产品（如皮革或羊毛）或吸入受感染动物产品中的炭疽孢子而感染炭疽病。他们也可能通过食用受感染动物的未煮熟的肉而感染。据了解，炭疽病不会在人与人之间传播。

炭疽感染有三种临床形式。皮肤炭疽是最常见的，占已报告病例的 95% 以上。据估计，全球每年发生 2000 例皮肤炭疽病例，是由孢子通过皮肤擦伤进入人体引起的。

炭疽病的鉴别诊断包括根据临床特征，相关标本包括PCR、革兰氏染色和培养，来自血液、胸腔积液、溃疡部位、脑脊液和粪便。有许多可用的技术。大多数检测是基于通过以下技术之一检测整个生物体、生物体抗原或生物体核酸：基于培养的常规方法；免疫学检测；基于核酸的检测；基于配体的检测；以及生物传感器。

驱动程序

炭疽病感染率不断上升

细菌感染的发病率在世界范围内不断上升。炭疽病是由炭疽芽孢杆菌引起的细菌感染，炭疽芽孢杆菌是一种需氧革兰氏阳性芽孢杆菌。根据炭疽芽孢杆菌孢子的进入途径，炭疽病主要以皮肤、肺部或胃肠道感染的形式出现。随后，受感染的皮肤区域会出现典型的黑色硬皮斑点，几周后开始松弛并最终脱落，留下疤痕。这些事件的进程非常典型，熟悉该疾病的医生通常不会漏诊，尽管这种情况很少见。肺炭疽是三种炭疽病中最致命的一种，其中的孢子一旦被吸入，就会在气管支气管淋巴结内发芽并繁殖。炭疽病是一种影响人类和动物的有害疾病。它是一种由炭疽芽孢杆菌引起的危及生命的感染。因此，炭疽病感染的发病率和流行率不断上升，需要更多灵敏度更高的诊断方法来检测少量感染。

全球患炭疽病的人数增加是推动炭疽病治疗市场增长的主要因素之一。研究人员为开发新型干预措施而获得的财政支持增加，以及平民和军队接触炭疽杆菌的威胁增加，加速了市场的增长。研发项目数量的增加，以及促进创新有效治疗的新发展的公私伙伴关系的增加，进一步影响了市场。

增加研究资金和开发针对炭疽病治疗人群的新疗法

研发是改进治疗不同类型患者的程序的先决条件。全球各国对炭疽病治疗的需求都在增加。这就是为什么各公司不断专注于研发，以成功为患者提供有效的治疗。近年来，许多诊断方法的出现将诊断提升到了新的水平，许多方法甚至可以用来检测人体内最小量的寄生虫。

这些新的诊断方法将推动市场向前发展。随着研究资金的增加和治疗炭疽病的新疗法的开发。有几种新型和现有的抗生素以及毒素抑制剂显示出越来越大的前景，它们针对细菌生长和毒素产生，有效对抗炭疽细菌。

随着公司不断从事开发活动，市场上推出了更多创新产品。开发的新工具能够以更高的有效率在更短的时间间隔内检测细菌感染，从而使消费者能够在正确的时间获得适当的治疗。因此，这意味着，预计不断增加的研发将成为中东和非洲炭疽病治疗市场增长的驱动力

机会

新品发布

人类感染通常是通过接触受感染的动物或动物产品，并可能表现为皮肤、吸入或胃肠道感染。炭疽病的全球发病率普遍上升。因此，全球越来越多的患者需要高效和先进的炭疽病治疗产品，以最大限度地降低因炭疽病死亡的风险。此外，发达国家的医疗保健系统更倾向于高进步、风险因素较少和先进的炭疽病治疗产品。因此，主要市场参与者高度关注产品发布。

因此，不断增加的产品发布为患者提供高效、先进的医疗产品，从而改善患者体验。新产品的发布不仅为公司带来了关注，还为公司在中东和非洲市场建立了影响力。产品发布的根本有利因素是促进了公司的业务增长。而新产品的发布为公司创造了收入来源，而产品发布所建立的收入来源可以持续多年。因此，据估计，新产品的发布有望为市场参与者带来巨大的机会，以提升他们在炭疽病治疗市场的业务增长。

限制/挑战

治疗费用高昂

产品成本是市场的主要因素。市场上有许多诊断选项，但由于成本高昂，大多数人倾向于避免进行诊断。由于诊断方法具有更高的灵敏度和特异性，因此测试成本也增加了。该程序的高成本是由于治疗的各种检查点以及使用高科技方式执行此类程序。由于技术先进设备的成本很高，因此程序成本也会相应增加，因此预计程序的高成本将阻碍市场的需求。

此外，无症状感染者必须经过非常特殊的测试才能识别出细菌，而这些测试成本高昂。由于炭疽病的诊断成本高昂，预计会抑制市场增长。由于识别治疗的成本过高，限制了医生和患者接受高质量和有效的解决方案。因此，治疗程序的高成本对整体治疗成本产生负面影响。因此，它将限制未来中低收入国家对治疗的需求。这表明，高成本的程序预计将成为中东和非洲炭疽病治疗市场增长的制约因素。

近期发展

2022 年 6 月，Emergent BioSolutions Inc. 宣布，美国食品药品监督管理局 (FDA) 接受了 AV7909 的生物制品许可申请 (BLA) 的审查，AV7909 是一种新的炭疽候选疫苗，用于评估 18 至 65 岁人群在疑似或确诊接触炭疽杆菌后，使用推荐的抗菌药物进行暴露后预防疾病。
2022 年 1 月，Alembic Pharmaceuticals Limited 宣布，该公司已获得美国食品药品监督管理局 (USFDA) 对其盐酸多西环素缓释片 USP、75 毫克、100 毫克、150 毫克和 200 毫克的简化新药申请 (ANDA) 的最终批准，该药仅用于治疗或预防已证实或强烈怀疑由易感细菌引起的感染。这扩大了公司的产品组合。

中东和非洲炭疽病治疗市场细分

根据类型、给药途径和最终用户，中东和非洲炭疽病治疗市场可分为三个显著的细分市场。细分市场之间的增长有助于您分析利基增长点和进入市场的策略，并确定您的核心应用领域和目标市场的差异。

类型

皮肤炭疽
肺炭疽
肠炭疽

根据类型，中东和非洲炭疽病治疗市场分为皮肤炭疽病、肺炭疽病和肠炭疽病。

给药途径

皮肤炭疽
肺炭疽
肠炭疽

根据给药途径，中东和非洲炭疽病治疗市场分为口服、肠外和其他途径。

最终用户

政府组织
医院
学术及研究机构，
其他的

炭疽病治疗市场

根据最终用户，中东和非洲炭疽病治疗市场分为政府组织、医院、学术和研究机构等。

炭疽病治疗市场区域分析/见解

对中东和非洲炭疽病治疗市场进行了分析，并按类型、给药途径和最终用户提供了市场规模洞察和趋势。

炭疽病治疗报告涉及的国家包括沙特阿拉伯、南非、阿联酋、以色列、埃及、中东其他地区和非洲。

由于发展中地区的技术进步日益加快，南非有望占据主导地位。

报告的国家部分还提供了影响市场当前和未来趋势的各个市场影响因素和市场监管变化。下游和上游价值链分析、技术趋势和波特五力分析、案例研究等数据点是用于预测各个国家市场情景的一些指标。此外，在提供国家数据的预测分析时，还考虑了中东和非洲品牌的存在和可用性以及它们因来自本地和国内品牌的激烈或稀缺竞争而面临的挑战、国内关税和贸易路线的影响。

竞争格局和炭疽病治疗市场份额分析

中东和非洲炭疽病治疗市场竞争格局提供了竞争对手的详细信息。详细信息包括公司概况、公司财务状况、收入、市场潜力、研发投资、新市场计划、中东和非洲业务、生产基地和设施、生产能力、公司优势和劣势、产品发布、产品宽度和广度以及应用主导地位。以上提供的数据点仅与公司对炭疽病治疗市场的关注有关。

市场的一些参与者包括 Alembic Pharmaceuticals、Sun Pharmaceutical Industries Ltd.、Zydus Group、Bayer AG、Pfizer Inc.、Lupin、Teva Pharmaceutical Industries Ltd.、ARISTO Pharmaceuticals Private Limited 等。

研究方法

数据收集和基准年分析是使用具有大样本量的数据收集模块完成的。使用市场统计和连贯模型分析和估计市场数据。此外，市场份额分析和关键趋势分析是市场报告中的主要成功因素。DBMR 研究团队使用的关键研究方法是数据三角测量，其中包括数据挖掘、数据变量对市场影响的分析以及主要（行业专家）验证。除此之外，数据模型还包括供应商定位网格、市场时间线分析、市场概览和指南、公司定位网格、公司市场份额分析、测量标准、中东和非洲与地区以及供应商份额分析。如有进一步询问，请要求分析师致电。

SKU-68921

Get online access to the report on the World's First Market Intelligence Cloud

Click on image to enlarge

Interactive Data Analysis Dashboard
Company Analysis Dashboard for high growth potential opportunities
Research Analyst Access for customization & queries
Competitor Analysis with Interactive dashboard
Latest News, Updates & Trend analysis
Harness the Power of Benchmark Analysis for Comprehensive Competitor Tracking

Request for Demo

表格列表

TABLE 1 POPULATION AT RISK (IN MILLIONS) BY REGION, LAND USE AND OCCUPATIONAL EXPOSURE, 2020-

TABLE 2 VACCINES IN DEVELOPMENT

TABLE 3 ANTIBIOTIC CONSUMPTION ESTIMATES BY GBD SUPER-REGION AND GBD REGION, FOR THE YEAR 2018-

TABLE 4 COUNTRY DATA OF ANTIBIOTICS CONSUMPTION-

TABLE 5 RECENT M&A IN ANTHRAX MARKET-

TABLE 6 ANTIBIOTICS MEDICINES

TABLE 7 FDA REQUIRES THE FOLLOWING SCENARIO BEFORE A DRUG IS APPROVED

TABLE 8 MIDDLE EAST & AFRICA ANTHRAX TREATMENT MARKET, TYPE, 2020-2029 (USD MILLION)

TABLE 9 MIDDLE EAST & AFRICA CUTANEOUS ANTHRAX IN ANTHRAX TREATMENT MARKET, BY REGION, 2020-2029 (USD MILLION)

TABLE 10 MIDDLE EAST & AFRICA CUTANEOUS ANTHRAX TREATMENT MARKET, BY TYPE, 2020-2029 (USD MILLION)

TABLE 11 MIDDLE EAST & AFRICA ANTIBIOTICS IN ANTHRAX TREATMENT MARKET, BY TYPE, 2020-2029 (USD MILLION)

TABLE 12 MIDDLE EAST & AFRICA BY DRUGS ANTHRAX TREATMENT MARKET, BY TYPE, 2020-2029 (USD MILLION)

TABLE 13 MIDDLE EAST & AFRICA BY PRODUCT TYPES ANTHRAX TREATMENT MARKET, BY TYPE, 2020-2029 (USD MILLION)

TABLE 14 MIDDLE EAST & AFRICA BRANDED IN ANTHRAX TREATMENT MARKET, BY TYPE, 2020-2029 (USD MILLION)

TABLE 15 MIDDLE EAST & AFRICA ANTITOXIN IN ANTHRAX TREATMENT MARKET, BY TYPE, 2020-2029 (USD MILLION)

TABLE 16 MIDDLE EAST & AFRICA VACCINES IN ANTHRAX TREATMENT MARKET, BY TYPE, 2020-2029 (USD MILLION)

TABLE 17 MIDDLE EAST & AFRICA PULMONARY ANTHRAX IN ANTHRAX TREATMENT MARKET, BY REGION, 2020-2029 (USD MILLION)

TABLE 18 MIDDLE EAST & AFRICA PULMONARY ANTHRAX TREATMENT MARKET, BY TYPE, 2020-2029 (USD MILLION)

TABLE 19 MIDDLE EAST & AFRICA ANTIBIOTICS IN ANTHRAX TREATMENT MARKET, BY TYPE, 2020-2029 (USD MILLION)

TABLE 20 MIDDLE EAST & AFRICA BY DRUGS ANTHRAX TREATMENT MARKET, BY TYPE, 2020-2029 (USD MILLION)

TABLE 21 MIDDLE EAST & AFRICA BY PRODUCT TYPES ANTHRAX TREATMENT MARKET, BY TYPE, 2020-2029 (USD MILLION)

TABLE 22 MIDDLE EAST & AFRICA BRANDED IN ANTHRAX TREATMENT MARKET, BY TYPE, 2020-2029 (USD MILLION)

TABLE 23 MIDDLE EAST & AFRICA ANTITOXIN IN ANTHRAX TREATMENT MARKET, BY TYPE, 2020-2029 (USD MILLION)

TABLE 24 MIDDLE EAST & AFRICA VACCINES IN ANTHRAX TREATMENT MARKET, BY TYPE, 2020-2029 (USD MILLION)

TABLE 25 MIDDLE EAST & AFRICA INTESTINAL ANTHRAX IN ANTHRAX TREATMENT MARKET, BY REGION, 2020-2029 (USD MILLION)

TABLE 26 MIDDLE EAST & AFRICA INTESTINAL ANTHRAX IN ANTHRAX TREATMENT MARKET, BY TYPE, 2020-2029 (USD MILLION)

TABLE 27 MIDDLE EAST & AFRICA ANTIBIOTICS IN ANTHRAX TREATMENT MARKET, BY TYPE, 2020-2029 (USD MILLION)

TABLE 28 MIDDLE EAST & AFRICA BY DRUGS ANTHRAX TREATMENT MARKET, BY TYPE, 2020-2029 (USD MILLION)

TABLE 29 MIDDLE EAST & AFRICA BY PRODUCT TYPES ANTHRAX TREATMENT MARKET, BY TYPE, 2020-2029 (USD MILLION)

TABLE 30 MIDDLE EAST & AFRICA BRANDED IN ANTHRAX TREATMENT MARKET, BY TYPE, 2020-2029 (USD MILLION)

TABLE 31 MIDDLE EAST & AFRICA ANTITOXIN IN ANTHRAX TREATMENT MARKET, BY TYPE, 2020-2029 (USD MILLION)

TABLE 32 MIDDLE EAST & AFRICA VACCINES IN ANTHRAX TREATMENT MARKET, BY TYPE, 2020-2029 (USD MILLION)

TABLE 33 MIDDLE EAST & AFRICA ANTHRAX TREATMENT MARKET, BY ROUTE OF ADMINISTRATION, 2020-2029 (USD MILLION)

TABLE 34 MIDDLE EAST & AFRICA PARENTERAL IN ANTHRAX TREATMENT MARKET, BY REGION, 2020-2029 (USD MILLION)

TABLE 35 MIDDLE EAST & AFRICA ORAL IN ANTHRAX TREATMENT MARKET, BY REGION, 2020-2029 (USD MILLION)

TABLE 36 MIDDLE EAST & AFRICA OTHERS IN ANTHRAX TREATMENT MARKET, BY REGION, 2020-2029 (USD MILLION)

TABLE 37 MIDDLE EAST & AFRICA ANTHRAX TREATMENT MARKET, BY END USER, 2020-2029 (USD MILLION)

TABLE 38 MIDDLE EAST & AFRICA GOVERNMENT ORGANIZATION IN ANTHRAX TREATMENT MARKET, BY REGION, 2020-2029 (USD MILLION)

TABLE 39 MIDDLE EAST & AFRICA HOSPITALS IN ANTHRAX TREATMENT MARKET, BY REGION, 2020-2029 (USD MILLION)

TABLE 40 MIDDLE EAST & AFRICA ACADEMIC AND RESEARCH IN ANTHRAX TREATMENT MARKET, BY REGION, 2020-2029 (USD MILLION)

TABLE 41 MIDDLE EAST & AFRICA OTHERS IN ANTHRAX TREATMENT MARKET, BY REGION, 2020-2029 (USD MILLION)

TABLE 42 MIDDLE EAST AND AFRICA ANTHRAX TREATMENT MARKET, BY COUNTRY, 2020-2029 (USD MILLION)

TABLE 43 MIDDLE EAST AND AFRICA ANTHRAX TREATMENT MARKET, BY TYPE, 2020-2029 (USD MILLION)

TABLE 44 MIDDLE EAST AND AFRICA CUTANEOUS ANTHRAX TREATMENT MARKET, BY TYPE, 2020-2029 (USD MILLION)

TABLE 45 MIDDLE EAST AND AFRICA ANTIBIOTICS ANTHRAX TREATMENT MARKET, BY TYPE, 2020-2029 (USD MILLION)

TABLE 46 MIDDLE EAST AND AFRICA BY DRUGS ANTHRAX TREATMENT MARKET, BY TYPE, 2020-2029 (USD MILLION)

TABLE 47 MIDDLE EAST AND AFRICA BY DRUGS ANTHRAX TREATMENT MARKET, BY TYPE, 2020-2029 (UNITS)

TABLE 48 MIDDLE EAST AND AFRICA BY DRUGS ANTHRAX TREATMENT MARKET, BY TYPE, 2020-2029 (ASP)

TABLE 49 MIDDLE EAST AND AFRICA BY PRODUCT TYPE ANTHRAX TREATMENT MARKET, BY TYPE, 2020-2029 (USD MILLION)

TABLE 50 MIDDLE EAST AND AFRICA BRANDED ANTHRAX TREATMENT MARKET, BY TYPE, 2020-2029 (USD MILLION)

TABLE 51 MIDDLE EAST AND AFRICA BRANDED ANTHRAX TREATMENT MARKET, BY TYPE, 2020-2029 (UNITS)

TABLE 52 MIDDLE EAST AND AFRICA BRANDED ANTHRAX TREATMENT MARKET, BY TYPE, 2020-2029 (UNITS)

TABLE 53 MIDDLE EAST AND AFRICA ANTITOXIN ANTHRAX TREATMENT MARKET, BY TYPE, 2020-2029 (USD MILLION)

TABLE 54 MIDDLE EAST AND AFRICA BRANDED ANTHRAX TREATMENT MARKET, BY TYPE, 2020-2029 (UNITS)

TABLE 55 MIDDLE EAST AND AFRICA BRANDED ANTHRAX TREATMENT MARKET, BY TYPE, 2020-2029 (ASP)

TABLE 56 MIDDLE EAST AND AFRICA VACCINE ANTHRAX TREATMENT MARKET, BY TYPE, 2020-2029 (USD MILLION)

TABLE 57 MIDDLE EAST AND AFRICA BRANDED ANTHRAX TREATMENT MARKET, BY TYPE, 2020-2029 (UNITS)

TABLE 58 MIDDLE EAST AND AFRICA BRANDED TYPES ANTHRAX TREATMENT MARKET, BY TYPE, 2020-2029 (ASP)

TABLE 59 MIDDLE EAST AND AFRICA PULMONARY ANTHRAX TREATMENT MARKET, BY TYPE, 2020-2029 (USD MILLION)

TABLE 60 MIDDLE EAST AND AFRICA ANTIBIOTICS ANTHRAX TREATMENT MARKET, BY TYPE, 2020-2029 (USD MILLION)

TABLE 61 MIDDLE EAST AND AFRICA BY DRUGS ANTHRAX TREATMENT MARKET, BY TYPE, 2020-2029 (USD MILLION)

TABLE 62 MIDDLE EAST AND AFRICA BY DRUGS ANTHRAX TREATMENT MARKET, BY TYPE, 2020-2029 (UNITS)

TABLE 63 MIDDLE EAST AND AFRICA BY DRUGS ANTHRAX TREATMENT MARKET, BY TYPE, 2020-2029 (ASP)

TABLE 64 MIDDLE EAST AND AFRICA BY PRODUCT TYPE ANTHRAX TREATMENT MARKET, BY TYPE, 2020-2029 (USD MILLION)

TABLE 65 MIDDLE EAST AND AFRICA BRANDED ANTHRAX TREATMENT MARKET, BY TYPE, 2020-2029 (USD MILLION)

TABLE 66 MIDDLE EAST AND AFRICA BRANDED ANTHRAX TREATMENT MARKET, BY TYPE, 2020-2029 (UNITS)

TABLE 67 MIDDLE EAST AND AFRICA BRANDED ANTHRAX TREATMENT MARKET, BY TYPE, 2020-2029 (UNITS)

TABLE 68 MIDDLE EAST AND AFRICA ANTITOXIN ANTHRAX TREATMENT MARKET, BY TYPE, 2020-2029 (USD MILLION)

TABLE 69 MIDDLE EAST AND AFRICA BRANDED ANTHRAX TREATMENT MARKET, BY TYPE, 2020-2029 (UNITS)

TABLE 70 MIDDLE EAST AND AFRICA BRANDED ANTHRAX TREATMENT MARKET, BY TYPE, 2020-2029 (ASP)

TABLE 71 MIDDLE EAST AND AFRICA VACCINE ANTHRAX TREATMENT MARKET, BY TYPE, 2020-2029 (USD MILLION)

TABLE 72 MIDDLE EAST AND AFRICA BRANDED ANTHRAX TREATMENT MARKET, BY TYPE, 2020-2029 (UNITS)

TABLE 73 MIDDLE EAST AND AFRICA BRANDED TYPES ANTHRAX TREATMENT MARKET, BY TYPE, 2020-2029 (ASP)

TABLE 74 MIDDLE EAST AND AFRICA INTESTINAL ANTHRAX TREATMENT MARKET, BY TYPE, 2020-2029 (USD MILLION)

TABLE 75 MIDDLE EAST AND AFRICA ANTIBIOTICS ANTHRAX TREATMENT MARKET, BY TYPE, 2020-2029 (USD MILLION)

TABLE 76 MIDDLE EAST AND AFRICA BY DRUGS ANTHRAX TREATMENT MARKET, BY TYPE, 2020-2029 (USD MILLION)

TABLE 77 MIDDLE EAST AND AFRICA BY DRUGS ANTHRAX TREATMENT MARKET, BY TYPE, 2020-2029 (UNITS)

TABLE 78 MIDDLE EAST AND AFRICA BY DRUGS ANTHRAX TREATMENT MARKET, BY TYPE, 2020-2029 (ASP)

TABLE 79 MIDDLE EAST AND AFRICA BY PRODUCT TYPE ANTHRAX TREATMENT MARKET, BY TYPE, 2020-2029 (USD MILLION)

TABLE 80 MIDDLE EAST AND AFRICA BRANDED ANTHRAX TREATMENT MARKET, BY TYPE, 2020-2029 (USD MILLION)

TABLE 81 MIDDLE EAST AND AFRICA BRANDED ANTHRAX TREATMENT MARKET, BY TYPE, 2020-2029 (UNITS)

TABLE 82 MIDDLE EAST AND AFRICA BRANDED ANTHRAX TREATMENT MARKET, BY TYPE, 2020-2029 (UNITS)

TABLE 83 MIDDLE EAST AND AFRICA ANTITOXIN ANTHRAX TREATMENT MARKET, BY TYPE, 2020-2029 (USD MILLION)

TABLE 84 MIDDLE EAST AND AFRICA BRANDED ANTHRAX TREATMENT MARKET, BY TYPE, 2020-2029 (UNITS)

TABLE 85 MIDDLE EAST AND AFRICA BRANDED ANTHRAX TREATMENT MARKET, BY TYPE, 2020-2029 (ASP)

TABLE 86 MIDDLE EAST AND AFRICA VACCINE ANTHRAX TREATMENT MARKET, BY TYPE, 2020-2029 (USD MILLION)

TABLE 87 MIDDLE EAST AND AFRICA BRANDED ANTHRAX TREATMENT MARKET, BY TYPE, 2020-2029 (UNITS)

TABLE 88 MIDDLE EAST AND AFRICA BRANDED TYPES ANTHRAX TREATMENT MARKET, BY TYPE, 2020-2029 (ASP)

TABLE 89 MIDDLE EAST AND AFRICA ANTHRAX TREATMENT MARKET, BY ROUTE OF ADMINISTRATION, 2020-2029 (USD MILLION)

TABLE 90 MIDDLE EAST AND AFRICA ANTHRAX TREATMENT MARKET, BY END USERS, 2020-2029 (USD MILLION)

TABLE 91 SOUTH AFRICA ANTHRAX TREATMENT MARKET, BY TYPE, 2020-2029 (USD MILLION)

TABLE 92 SOUTH AFRICA CUTANEOUS ANTHRAX TREATMENT MARKET, BY TYPE, 2020-2029 (USD MILLION)

TABLE 93 SOUTH AFRICA ANTIBIOTICS ANTHRAX TREATMENT MARKET, BY TYPE, 2020-2029 (USD MILLION)

TABLE 94 SOUTH AFRICA BY DRUGS ANTHRAX TREATMENT MARKET, BY TYPE, 2020-2029 (USD MILLION)

TABLE 95 SOUTH AFRICA BY DRUGS ANTHRAX TREATMENT MARKET, BY TYPE, 2020-2029 (UNITS)

TABLE 96 SOUTH AFRICA BY PRODUCT TYPE ANTHRAX TREATMENT MARKET, BY TYPE, 2020-2029 (USD MILLION)

TABLE 97 SOUTH AFRICA BRANDED ANTHRAX TREATMENT MARKET, BY TYPE, 2020-2029 (USD MILLION)

TABLE 98 SOUTH AFRICA BRANDED ANTHRAX TREATMENT MARKET, BY TYPE, 2020-2029 (UNITS)

TABLE 99 SOUTH AFRICA ANTITOXIN ANTHRAX TREATMENT MARKET, BY TYPE, 2020-2029 (USD MILLION)

TABLE 100 SOUTH AFRICA BRANDED ANTHRAX TREATMENT MARKET, BY TYPE, 2020-2029 (UNITS)

TABLE 101 SOUTH AFRICA VACCINE ANTHRAX TREATMENT MARKET, BY TYPE, 2020-2029 (USD MILLION)

TABLE 102 SOUTH AFRICA BRANDED ANTHRAX TREATMENT MARKET, BY TYPE, 2020-2029 (UNITS)

TABLE 103 SOUTH AFRICA PULMONARY ANTHRAX TREATMENT MARKET, BY TYPE, 2020-2029 (USD MILLION)

TABLE 104 SOUTH AFRICA ANTIBIOTICS ANTHRAX TREATMENT MARKET, BY TYPE, 2020-2029 (USD MILLION)

TABLE 105 SOUTH AFRICA BY DRUGS ANTHRAX TREATMENT MARKET, BY TYPE, 2020-2029 (USD MILLION)

TABLE 106 SOUTH AFRICA BY DRUGS ANTHRAX TREATMENT MARKET, BY TYPE, 2020-2029 (UNITS)

TABLE 107 SOUTH AFRICA BY PRODUCT TYPE ANTHRAX TREATMENT MARKET, BY TYPE, 2020-2029 (USD MILLION)

TABLE 108 SOUTH AFRICA BRANDED ANTHRAX TREATMENT MARKET, BY TYPE, 2020-2029 (USD MILLION)

TABLE 109 SOUTH AFRICA BRANDED ANTHRAX TREATMENT MARKET, BY TYPE, 2020-2029 (UNITS)

TABLE 110 SOUTH AFRICA ANTITOXIN ANTHRAX TREATMENT MARKET, BY TYPE, 2020-2029 (USD MILLION)

TABLE 111 SOUTH AFRICA BRANDED ANTHRAX TREATMENT MARKET, BY TYPE, 2020-2029 (UNITS)

TABLE 112 SOUTH AFRICA VACCINE ANTHRAX TREATMENT MARKET, BY TYPE, 2020-2029 (USD MILLION)

TABLE 113 SOUTH AFRICA BRANDED ANTHRAX TREATMENT MARKET, BY TYPE, 2020-2029 (UNITS)

TABLE 114 SOUTH AFRICA INTESTINAL ANTHRAX TREATMENT MARKET, BY TYPE, 2020-2029 (USD MILLION)

TABLE 115 SOUTH AFRICA ANTIBIOTICS ANTHRAX TREATMENT MARKET, BY TYPE, 2020-2029 (USD MILLION)

TABLE 116 SOUTH AFRICA BY DRUGS ANTHRAX TREATMENT MARKET, BY TYPE, 2020-2029 (USD MILLION)

TABLE 117 SOUTH AFRICA BY DRUGS ANTHRAX TREATMENT MARKET, BY TYPE, 2020-2029 (UNITS)

TABLE 118 SOUTH AFRICA BY PRODUCT TYPE ANTHRAX TREATMENT MARKET, BY TYPE, 2020-2029 (USD MILLION)

TABLE 119 SOUTH AFRICA BRANDED ANTHRAX TREATMENT MARKET, BY TYPE, 2020-2029 (USD MILLION)

TABLE 120 SOUTH AFRICA BRANDED ANTHRAX TREATMENT MARKET, BY TYPE, 2020-2029 (UNITS)

TABLE 121 SOUTH AFRICA ANTITOXIN ANTHRAX TREATMENT MARKET, BY TYPE, 2020-2029 (USD MILLION)

TABLE 122 SOUTH AFRICA BRANDED ANTHRAX TREATMENT MARKET, BY TYPE, 2020-2029 (UNITS)

TABLE 123 SOUTH AFRICA VACCINE ANTHRAX TREATMENT MARKET, BY TYPE, 2020-2029 (USD MILLION)

TABLE 124 SOUTH AFRICA BRANDED ANTHRAX TREATMENT MARKET, BY TYPE, 2020-2029 (UNITS)

TABLE 125 SOUTH AFRICA ANTHRAX TREATMENT MARKET, BY ROUTE OF ADMINISTRATION, 2020-2029 (USD MILLION)

TABLE 126 SOUTH AFRICA ANTHRAX TREATMENT MARKET, BY END USERS, 2020-2029 (USD MILLION)

TABLE 127 SAUDI ARABIA ANTHRAX TREATMENT MARKET, BY TYPE, 2020-2029 (USD MILLION)

TABLE 128 SAUDI ARABIA CUTANEOUS ANTHRAX TREATMENT MARKET, BY TYPE, 2020-2029 (USD MILLION)

TABLE 129 SAUDI ARABIA ANTIBIOTICS ANTHRAX TREATMENT MARKET, BY TYPE, 2020-2029 (USD MILLION)

TABLE 130 SAUDI ARABIA BY DRUGS ANTHRAX TREATMENT MARKET, BY TYPE, 2020-2029 (USD MILLION)

TABLE 131 SAUDI ARABIA BY DRUGS ANTHRAX TREATMENT MARKET, BY TYPE, 2020-2029 (UNITS)

TABLE 132 SAUDI ARABIA BY PRODUCT TYPE ANTHRAX TREATMENT MARKET, BY TYPE, 2020-2029 (USD MILLION)

TABLE 133 SAUDI ARABIA BRANDED ANTHRAX TREATMENT MARKET, BY TYPE, 2020-2029 (USD MILLION)

TABLE 134 SAUDI ARABIA BRANDED ANTHRAX TREATMENT MARKET, BY TYPE, 2020-2029 (UNITS)

TABLE 135 SAUDI ARABIA ANTITOXIN ANTHRAX TREATMENT MARKET, BY TYPE, 2020-2029 (USD MILLION)

TABLE 136 SAUDI ARABIA BRANDED ANTHRAX TREATMENT MARKET, BY TYPE, 2020-2029 (UNITS)

TABLE 137 SAUDI ARABIA VACCINE ANTHRAX TREATMENT MARKET, BY TYPE, 2020-2029 (USD MILLION)

TABLE 138 SAUDI ARABIA BRANDED ANTHRAX TREATMENT MARKET, BY TYPE, 2020-2029 (UNITS)

TABLE 139 SAUDI ARABIA PULMONARY ANTHRAX TREATMENT MARKET, BY TYPE, 2020-2029 (USD MILLION)

TABLE 140 SAUDI ARABIA ANTIBIOTICS ANTHRAX TREATMENT MARKET, BY TYPE, 2020-2029 (USD MILLION)

TABLE 141 SAUDI ARABIA BY DRUGS ANTHRAX TREATMENT MARKET, BY TYPE, 2020-2029 (USD MILLION)

TABLE 142 SAUDI ARABIA BY DRUGS ANTHRAX TREATMENT MARKET, BY TYPE, 2020-2029 (UNITS)

TABLE 143 SAUDI ARABIA BY PRODUCT TYPE ANTHRAX TREATMENT MARKET, BY TYPE, 2020-2029 (USD MILLION)

TABLE 144 SAUDI ARABIA BRANDED ANTHRAX TREATMENT MARKET, BY TYPE, 2020-2029 (USD MILLION)

TABLE 145 SAUDI ARABIA BRANDED ANTHRAX TREATMENT MARKET, BY TYPE, 2020-2029 (UNITS)

TABLE 146 SAUDI ARABIA ANTITOXIN ANTHRAX TREATMENT MARKET, BY TYPE, 2020-2029 (USD MILLION)

TABLE 147 SAUDI ARABIA BRANDED ANTHRAX TREATMENT MARKET, BY TYPE, 2020-2029 (UNITS)

TABLE 148 SAUDI ARABIA VACCINE ANTHRAX TREATMENT MARKET, BY TYPE, 2020-2029 (USD MILLION)

TABLE 149 SAUDI ARABIA BRANDED ANTHRAX TREATMENT MARKET, BY TYPE, 2020-2029 (UNITS)

TABLE 150 SAUDI ARABIA INTESTINAL ANTHRAX TREATMENT MARKET, BY TYPE, 2020-2029 (USD MILLION)

TABLE 151 SAUDI ARABIA ANTIBIOTICS ANTHRAX TREATMENT MARKET, BY TYPE, 2020-2029 (USD MILLION)

TABLE 152 SAUDI ARABIA BY DRUGS ANTHRAX TREATMENT MARKET, BY TYPE, 2020-2029 (USD MILLION)

TABLE 153 SAUDI ARABIA BY DRUGS ANTHRAX TREATMENT MARKET, BY TYPE, 2020-2029 (UNITS)

TABLE 154 SAUDI ARABIA BY PRODUCT TYPE ANTHRAX TREATMENT MARKET, BY TYPE, 2020-2029 (USD MILLION)

TABLE 155 SAUDI ARABIA BRANDED ANTHRAX TREATMENT MARKET, BY TYPE, 2020-2029 (USD MILLION)

TABLE 156 SAUDI ARABIA BRANDED ANTHRAX TREATMENT MARKET, BY TYPE, 2020-2029 (UNITS)

TABLE 157 SAUDI ARABIA ANTITOXIN ANTHRAX TREATMENT MARKET, BY TYPE, 2020-2029 (USD MILLION)

TABLE 158 SAUDI ARABIA BRANDED ANTHRAX TREATMENT MARKET, BY TYPE, 2020-2029 (UNITS)

TABLE 159 SAUDI ARABIA VACCINE ANTHRAX TREATMENT MARKET, BY TYPE, 2020-2029 (USD MILLION)

TABLE 160 SAUDI ARABIA BRANDED ANTHRAX TREATMENT MARKET, BY TYPE, 2020-2029 (UNITS)

TABLE 161 SAUDI ARABIA ANTHRAX TREATMENT MARKET, BY ROUTE OF ADMINISTRATION, 2020-2029 (USD MILLION)

TABLE 162 SAUDI ARABIA ANTHRAX TREATMENT MARKET, BY END USERS, 2020-2029 (USD MILLION)

TABLE 163 U.A.E ANTHRAX TREATMENT MARKET, BY TYPE, 2020-2029 (USD MILLION)

TABLE 164 U.A.E CUTANEOUS ANTHRAX TREATMENT MARKET, BY TYPE, 2020-2029 (USD MILLION)

TABLE 165 U.A.E ANTIBIOTICS ANTHRAX TREATMENT MARKET, BY TYPE, 2020-2029 (USD MILLION)

TABLE 166 U.A.E BY DRUGS ANTHRAX TREATMENT MARKET, BY TYPE, 2020-2029 (USD MILLION)

TABLE 167 U.A.E BY DRUGS ANTHRAX TREATMENT MARKET, BY TYPE, 2020-2029 (UNITS)

TABLE 168 U.A.E BY PRODUCT TYPE ANTHRAX TREATMENT MARKET, BY TYPE, 2020-2029 (USD MILLION)

TABLE 169 U.A.E BRANDED ANTHRAX TREATMENT MARKET, BY TYPE, 2020-2029 (USD MILLION)

TABLE 170 U.A.E BRANDED ANTHRAX TREATMENT MARKET, BY TYPE, 2020-2029 (UNITS)

TABLE 171 U.A.E ANTITOXIN ANTHRAX TREATMENT MARKET, BY TYPE, 2020-2029 (USD MILLION)

TABLE 172 U.A.E BRANDED ANTHRAX TREATMENT MARKET, BY TYPE, 2020-2029 (UNITS)

TABLE 173 U.A.E VACCINE ANTHRAX TREATMENT MARKET, BY TYPE, 2020-2029 (USD MILLION)

TABLE 174 U.A.E BRANDED ANTHRAX TREATMENT MARKET, BY TYPE, 2020-2029 (UNITS)

TABLE 175 U.A.E PULMONARY ANTHRAX TREATMENT MARKET, BY TYPE, 2020-2029 (USD MILLION)

TABLE 176 U.A.E ANTIBIOTICS ANTHRAX TREATMENT MARKET, BY TYPE, 2020-2029 (USD MILLION)

TABLE 177 U.A.E BY DRUGS ANTHRAX TREATMENT MARKET, BY TYPE, 2020-2029 (USD MILLION)

TABLE 178 U.A.E BY DRUGS ANTHRAX TREATMENT MARKET, BY TYPE, 2020-2029 (UNITS)

TABLE 179 U.A.E BY PRODUCT TYPE ANTHRAX TREATMENT MARKET, BY TYPE, 2020-2029 (USD MILLION)

TABLE 180 U.A.E BRANDED ANTHRAX TREATMENT MARKET, BY TYPE, 2020-2029 (USD MILLION)

TABLE 181 U.A.E BRANDED ANTHRAX TREATMENT MARKET, BY TYPE, 2020-2029 (UNITS)

TABLE 182 U.A.E ANTITOXIN ANTHRAX TREATMENT MARKET, BY TYPE, 2020-2029 (USD MILLION)

TABLE 183 U.A.E BRANDED ANTHRAX TREATMENT MARKET, BY TYPE, 2020-2029 (UNITS)

TABLE 184 U.A.E VACCINE ANTHRAX TREATMENT MARKET, BY TYPE, 2020-2029 (USD MILLION)

TABLE 185 U.A.E BRANDED ANTHRAX TREATMENT MARKET, BY TYPE, 2020-2029 (UNITS)

TABLE 186 U.A.E INTESTINAL ANTHRAX TREATMENT MARKET, BY TYPE, 2020-2029 (USD MILLION)

TABLE 187 U.A.E ANTIBIOTICS ANTHRAX TREATMENT MARKET, BY TYPE, 2020-2029 (USD MILLION)

TABLE 188 U.A.E BY DRUGS ANTHRAX TREATMENT MARKET, BY TYPE, 2020-2029 (USD MILLION)

TABLE 189 U.A.E BY DRUGS ANTHRAX TREATMENT MARKET, BY TYPE, 2020-2029 (UNITS)

TABLE 190 U.A.E BY PRODUCT TYPE ANTHRAX TREATMENT MARKET, BY TYPE, 2020-2029 (USD MILLION)

TABLE 191 U.A.E BRANDED ANTHRAX TREATMENT MARKET, BY TYPE, 2020-2029 (USD MILLION)

TABLE 192 U.A.E BRANDED ANTHRAX TREATMENT MARKET, BY TYPE, 2020-2029 (UNITS)

TABLE 193 U.A.E ANTITOXIN ANTHRAX TREATMENT MARKET, BY TYPE, 2020-2029 (USD MILLION)

TABLE 194 U.A.E BRANDED ANTHRAX TREATMENT MARKET, BY TYPE, 2020-2029 (UNITS)

TABLE 195 U.A.E VACCINE ANTHRAX TREATMENT MARKET, BY TYPE, 2020-2029 (USD MILLION)

TABLE 196 U.A.E BRANDED ANTHRAX TREATMENT MARKET, BY TYPE, 2020-2029 (UNITS)

TABLE 197 U.A.E ANTHRAX TREATMENT MARKET, BY ROUTE OF ADMINISTRATION, 2020-2029 (USD MILLION)

TABLE 198 U.A.E ANTHRAX TREATMENT MARKET, BY END USERS, 2020-2029 (USD MILLION)

TABLE 199 EGYPT ANTHRAX TREATMENT MARKET, BY TYPE, 2020-2029 (USD MILLION)

TABLE 200 EGYPT CUTANEOUS ANTHRAX TREATMENT MARKET, BY TYPE, 2020-2029 (USD MILLION)

TABLE 201 EGYPT ANTIBIOTICS ANTHRAX TREATMENT MARKET, BY TYPE, 2020-2029 (USD MILLION)

TABLE 202 EGYPT BY DRUGS ANTHRAX TREATMENT MARKET, BY TYPE, 2020-2029 (USD MILLION)

TABLE 203 EGYPT BY DRUGS ANTHRAX TREATMENT MARKET, BY TYPE, 2020-2029 (UNITS)

TABLE 204 EGYPT BY PRODUCT TYPE ANTHRAX TREATMENT MARKET, BY TYPE, 2020-2029 (USD MILLION)

TABLE 205 EGYPT BRANDED ANTHRAX TREATMENT MARKET, BY TYPE, 2020-2029 (USD MILLION)

TABLE 206 EGYPT BRANDED ANTHRAX TREATMENT MARKET, BY TYPE, 2020-2029 (UNITS)

TABLE 207 EGYPT ANTITOXIN ANTHRAX TREATMENT MARKET, BY TYPE, 2020-2029 (USD MILLION)

TABLE 208 EGYPT BRANDED ANTHRAX TREATMENT MARKET, BY TYPE, 2020-2029 (UNITS)

TABLE 209 EGYPT VACCINE ANTHRAX TREATMENT MARKET, BY TYPE, 2020-2029 (USD MILLION)

TABLE 210 EGYPT BRANDED ANTHRAX TREATMENT MARKET, BY TYPE, 2020-2029 (UNITS)

TABLE 211 EGYPT PULMONARY ANTHRAX TREATMENT MARKET, BY TYPE, 2020-2029 (USD MILLION)

TABLE 212 EGYPT ANTIBIOTICS ANTHRAX TREATMENT MARKET, BY TYPE, 2020-2029 (USD MILLION)

TABLE 213 EGYPT BY DRUGS ANTHRAX TREATMENT MARKET, BY TYPE, 2020-2029 (USD MILLION)

TABLE 214 EGYPT BY DRUGS ANTHRAX TREATMENT MARKET, BY TYPE, 2020-2029 (UNITS)

TABLE 215 EGYPT BY PRODUCT TYPE ANTHRAX TREATMENT MARKET, BY TYPE, 2020-2029 (USD MILLION)

TABLE 216 EGYPT BRANDED ANTHRAX TREATMENT MARKET, BY TYPE, 2020-2029 (USD MILLION)

TABLE 217 EGYPT BRANDED ANTHRAX TREATMENT MARKET, BY TYPE, 2020-2029 (UNITS)

TABLE 218 EGYPT ANTITOXIN ANTHRAX TREATMENT MARKET, BY TYPE, 2020-2029 (USD MILLION)

TABLE 219 EGYPT BRANDED ANTHRAX TREATMENT MARKET, BY TYPE, 2020-2029 (UNITS)

TABLE 220 EGYPT VACCINE ANTHRAX TREATMENT MARKET, BY TYPE, 2020-2029 (USD MILLION)

TABLE 221 EGYPT BRANDED ANTHRAX TREATMENT MARKET, BY TYPE, 2020-2029 (UNITS)

TABLE 222 EGYPT INTESTINAL ANTHRAX TREATMENT MARKET, BY TYPE, 2020-2029 (USD MILLION)

TABLE 223 EGYPT ANTIBIOTICS ANTHRAX TREATMENT MARKET, BY TYPE, 2020-2029 (USD MILLION)

TABLE 224 EGYPT BY DRUGS ANTHRAX TREATMENT MARKET, BY TYPE, 2020-2029 (USD MILLION)

TABLE 225 EGYPT BY DRUGS ANTHRAX TREATMENT MARKET, BY TYPE, 2020-2029 (UNITS)

TABLE 226 EGYPT BY PRODUCT TYPE ANTHRAX TREATMENT MARKET, BY TYPE, 2020-2029 (USD MILLION)

TABLE 227 EGYPT BRANDED ANTHRAX TREATMENT MARKET, BY TYPE, 2020-2029 (USD MILLION)

TABLE 228 EGYPT BRANDED ANTHRAX TREATMENT MARKET, BY TYPE, 2020-2029 (UNITS)

TABLE 229 EGYPT ANTITOXIN ANTHRAX TREATMENT MARKET, BY TYPE, 2020-2029 (USD MILLION)

TABLE 230 EGYPT BRANDED ANTHRAX TREATMENT MARKET, BY TYPE, 2020-2029 (UNITS)

TABLE 231 EGYPT VACCINE ANTHRAX TREATMENT MARKET, BY TYPE, 2020-2029 (USD MILLION)

TABLE 232 EGYPT BRANDED ANTHRAX TREATMENT MARKET, BY TYPE, 2020-2029 (UNITS)

TABLE 233 EGYPT ANTHRAX TREATMENT MARKET, BY ROUTE OF ADMINISTRATION, 2020-2029 (USD MILLION)

TABLE 234 EGYPT ANTHRAX TREATMENT MARKET, BY END USERS, 2020-2029 (USD MILLION)

TABLE 235 ISRAEL ANTHRAX TREATMENT MARKET, BY TYPE, 2020-2029 (USD MILLION)

TABLE 236 ISRAEL CUTANEOUS ANTHRAX TREATMENT MARKET, BY TYPE, 2020-2029 (USD MILLION)

TABLE 237 ISRAEL ANTIBIOTICS ANTHRAX TREATMENT MARKET, BY TYPE, 2020-2029 (USD MILLION)

TABLE 238 ISRAEL BY DRUGS ANTHRAX TREATMENT MARKET, BY TYPE, 2020-2029 (USD MILLION)

TABLE 239 ISRAEL BY DRUGS ANTHRAX TREATMENT MARKET, BY TYPE, 2020-2029 (UNITS)

TABLE 240 ISRAEL BY PRODUCT TYPE ANTHRAX TREATMENT MARKET, BY TYPE, 2020-2029 (USD MILLION)

TABLE 241 ISRAEL BRANDED ANTHRAX TREATMENT MARKET, BY TYPE, 2020-2029 (USD MILLION)

TABLE 242 ISRAEL BRANDED ANTHRAX TREATMENT MARKET, BY TYPE, 2020-2029 (UNITS)

TABLE 243 ISRAEL ANTITOXIN ANTHRAX TREATMENT MARKET, BY TYPE, 2020-2029 (USD MILLION)

TABLE 244 ISRAEL BRANDED ANTHRAX TREATMENT MARKET, BY TYPE, 2020-2029 (UNITS)

TABLE 245 ISRAEL VACCINE ANTHRAX TREATMENT MARKET, BY TYPE, 2020-2029 (USD MILLION)

TABLE 246 ISRAEL BRANDED ANTHRAX TREATMENT MARKET, BY TYPE, 2020-2029 (UNITS)

TABLE 247 ISRAEL PULMONARY ANTHRAX TREATMENT MARKET, BY TYPE, 2020-2029 (USD MILLION)

TABLE 248 ISRAEL ANTIBIOTICS ANTHRAX TREATMENT MARKET, BY TYPE, 2020-2029 (USD MILLION)

TABLE 249 ISRAEL BY DRUGS ANTHRAX TREATMENT MARKET, BY TYPE, 2020-2029 (USD MILLION)

TABLE 250 ISRAEL BY DRUGS ANTHRAX TREATMENT MARKET, BY TYPE, 2020-2029 (UNITS)

TABLE 251 ISRAEL BY PRODUCT TYPE ANTHRAX TREATMENT MARKET, BY TYPE, 2020-2029 (USD MILLION)

TABLE 252 ISRAEL BRANDED ANTHRAX TREATMENT MARKET, BY TYPE, 2020-2029 (USD MILLION)

TABLE 253 ISRAEL BRANDED ANTHRAX TREATMENT MARKET, BY TYPE, 2020-2029 (UNITS)

TABLE 254 ISRAEL ANTITOXIN ANTHRAX TREATMENT MARKET, BY TYPE, 2020-2029 (USD MILLION)

TABLE 255 ISRAEL BRANDED ANTHRAX TREATMENT MARKET, BY TYPE, 2020-2029 (UNITS)

TABLE 256 ISRAEL VACCINE ANTHRAX TREATMENT MARKET, BY TYPE, 2020-2029 (USD MILLION)

TABLE 257 ISRAEL BRANDED ANTHRAX TREATMENT MARKET, BY TYPE, 2020-2029 (UNITS)

TABLE 258 ISRAEL INTESTINAL ANTHRAX TREATMENT MARKET, BY TYPE, 2020-2029 (USD MILLION)

TABLE 259 ISRAEL ANTIBIOTICS ANTHRAX TREATMENT MARKET, BY TYPE, 2020-2029 (USD MILLION)

TABLE 260 ISRAEL BY DRUGS ANTHRAX TREATMENT MARKET, BY TYPE, 2020-2029 (USD MILLION)

TABLE 261 ISRAEL BY DRUGS ANTHRAX TREATMENT MARKET, BY TYPE, 2020-2029 (UNITS)

TABLE 262 ISRAEL BY PRODUCT TYPE ANTHRAX TREATMENT MARKET, BY TYPE, 2020-2029 (USD MILLION)

TABLE 263 ISRAEL BRANDED ANTHRAX TREATMENT MARKET, BY TYPE, 2020-2029 (USD MILLION)

TABLE 264 ISRAEL BRANDED ANTHRAX TREATMENT MARKET, BY TYPE, 2020-2029 (UNITS)

TABLE 265 ISRAEL ANTITOXIN ANTHRAX TREATMENT MARKET, BY TYPE, 2020-2029 (USD MILLION)

TABLE 266 ISRAEL BRANDED ANTHRAX TREATMENT MARKET, BY TYPE, 2020-2029 (UNITS)

TABLE 267 ISRAEL VACCINE ANTHRAX TREATMENT MARKET, BY TYPE, 2020-2029 (USD MILLION)

TABLE 268 ISRAEL BRANDED ANTHRAX TREATMENT MARKET, BY TYPE, 2020-2029 (UNITS)

TABLE 269 ISRAEL ANTHRAX TREATMENT MARKET, BY ROUTE OF ADMINISTRATION, 2020-2029 (USD MILLION)

TABLE 270 ISRAEL ANTHRAX TREATMENT MARKET, BY END USERS, 2020-2029 (USD MILLION)

TABLE 271 REST OF MIDDLE EAST AND AFRICA ANTHRAX TREATMENT MARKET, BY TYPE, 2020-2029 (USD MILLION)

图片列表

FIGURE 1 MIDDLE EAST & AFRICA ANTHRAX TREATMENT MARKET: SEGMENTATION

FIGURE 2 MIDDLE EAST & AFRICA ANTHRAX TREATMENT MARKET: DATA TRIANGULATION

FIGURE 3 MIDDLE EAST & AFRICA ANTHRAX TREATMENT MARKET: DROC ANALYSIS

FIGURE 4 MIDDLE EAST & AFRICA ANTHRAX TREATMENT MARKET: REGIONAL VS COUNTRY MARKET ANALYSIS

FIGURE 5 MIDDLE EAST & AFRICA ANTHRAX TREATMENT MARKET: COMPANY RESEARCH ANALYSIS

FIGURE 6 MIDDLE EAST & AFRICA ANTHRAX TREATMENT MARKET: INTERVIEW DEMOGRAPHICS

FIGURE 7 MIDDLE EAST & AFRICA ANTHRAX TREATMENT MARKET: DBMR MARKET POSITION GRID

FIGURE 8 MIDDLE EAST & AFRICA ANTHRAX TREATMENT MARKET: MARKET APPLICATION COVERAGE GRID

FIGURE 9 MIDDLE EAST & AFRICA ANTHRAX TREATMENT MARKET: VENDOR SHARE ANALYSIS

FIGURE 10 MIDDLE EAST & AFRICA ANTHRAX TREATMENT MARKET: SEGMENTATION

FIGURE 11 MIDDLE EAST & AFRICA IS ANTICIPATED TO DOMINATE THE ANTHRAX TREATMENT MARKET AND GROW WITH THE HIGHEST CAGR IN THE FORECAST PERIOD OF 2022 TO 2029

FIGURE 12 INCREASING INCIDENCE AND PREVALENCE OF ANTHRAX INFECTIONS ARE EXPECTED TO DRIVE THE MIDDLE EAST & AFRICA ANTHRAX TREATMENT MARKET IN THE FORECAST PERIOD

FIGURE 13 TYPE SEGMENT IS EXPECTED TO ACCOUNT FOR THE LARGEST SHARE OF THE MIDDLE EAST & AFRICA ANTHRAX TREATMENT MARKET IN 2022 & 2029

FIGURE 14 MIDDLE EAST & AFRICA DISTRIBUTION OF OUTBREAKS BY COUNTRY AND GEOGRAPHIC LOCATIONS OF ANTHRAX EVENTS-

FIGURE 15 PATHOPHYSIOLOGY OF ANTHRAX-

FIGURE 16 FLOW CHART FOR SUSPECTED ANTHRAX EXPOSURE-

FIGURE 17 GC BIOPHARMA ANTHRAX CANDIDATE GC1109 IS IN PHASE 2 (NCT01624532).

FIGURE 18 BA-ISTAB IS A FUSION OF A B. ANTHRACIS SPECIFIC CWT WITH A POTENT MONOCLONAL ANTIBODY THAT NEUTRALIZE ANTHRAX TOXIN (PA).

FIGURE 19 TWO ROUTES BY WHICH VACCINATION CAN REDUCE INCIDENCE OF AMR-

FIGURE 20 DRIVERS, RESTRAINTS, OPPORTUNITIES AND CHALLENGES OF MIDDLE EAST & AFRICA ANTHRAX TREATMENT MARKET

FIGURE 21 MIDDLE EAST & AFRICA ANTHRAX TREATMENT MARKET : TYPE, 2021

FIGURE 22 MIDDLE EAST & AFRICA ANTHRAX TREATMENT MARKET : TYPE, 2022-2029 (USD MILLION)

FIGURE 23 MIDDLE EAST & AFRICA ANTHRAX TREATMENT MARKET : TYPE, CAGR (2022-2029)

FIGURE 24 MIDDLE EAST & AFRICA ANTHRAX TREATMENT MARKET : TYPE, LIFELINE CURVE

FIGURE 25 MIDDLE EAST & AFRICA ANTHRAX TREATMENT MARKET : BY ROUTE OF ADMINISTRATION, 2021

FIGURE 26 MIDDLE EAST & AFRICA ANTHRAX TREATMENT MARKET : BY ROUTE OF ADMINISTRATION, 2022-2029 (USD MILLION)

FIGURE 27 MIDDLE EAST & AFRICA ANTHRAX TREATMENT MARKET : BY ROUTE OF ADMINISTRATION, CAGR (2022-2029)

FIGURE 28 MIDDLE EAST & AFRICA ANTHRAX TREATMENT MARKET : BY ROUTE OF ADMINISTRATION, LIFELINE CURVE

FIGURE 29 MIDDLE EAST & AFRICA ANTHRAX TREATMENT MARKET : BY END USER, 2021

FIGURE 30 MIDDLE EAST & AFRICA ANTHRAX TREATMENT MARKET : BY END USER, 2022-2029 (USD MILLION)

FIGURE 31 MIDDLE EAST & AFRICA ANTHRAX TREATMENT MARKET : BY END USER, CAGR (2022-2029)

FIGURE 32 MIDDLE EAST & AFRICA ANTHRAX TREATMENT MARKET : BY END USER, LIFELINE CURVE

FIGURE 33 MIDDLE EAST AND AFRICA ANTHRAX TREATMENT MARKET: SNAPSHOT (2021)

FIGURE 34 MIDDLE EAST AND AFRICA ANTHRAX TREATMENT MARKET: BY COUNTRY (2021)

FIGURE 35 MIDDLE EAST AND AFRICA ANTHRAX TREATMENT MARKET: BY COUNTRY (2022 & 2029)

FIGURE 36 MIDDLE EAST AND AFRICA ANTHRAX TREATMENT MARKET: BY COUNTRY (2021 & 2029)

FIGURE 37 MIDDLE EAST AND AFRICA ANTHRAX TREATMENT MARKET: BY TYPE (2022-2029)

FIGURE 38 MIDDLE EAST & AFRICA ANTHRAX TREATMENT MARKET: COMPANY SHARE 2021(%)

查看详细信息

研究方法

数据收集和基准年分析是使用具有大样本量的数据收集模块完成的。该阶段包括通过各种来源和策略获取市场信息或相关数据。它包括提前检查和规划从过去获得的所有数据。它同样包括检查不同信息源中出现的信息不一致。使用市场统计和连贯模型分析和估计市场数据。此外，市场份额分析和关键趋势分析是市场报告中的主要成功因素。要了解更多信息，请请求分析师致电或下拉您的询问。

DBMR 研究团队使用的关键研究方法是数据三角测量，其中包括数据挖掘、数据变量对市场影响的分析和主要（行业专家）验证。数据模型包括供应商定位网格、市场时间线分析、市场概览和指南、公司定位网格、专利分析、定价分析、公司市场份额分析、测量标准、全球与区域和供应商份额分析。要了解有关研究方法的更多信息，请向我们的行业专家咨询。

可定制

Data Bridge Market Research 是高级形成性研究领域的领导者。我们为向现有和新客户提供符合其目标的数据和分析而感到自豪。报告可定制，包括目标品牌的价格趋势分析、了解其他国家的市场（索取国家列表）、临床试验结果数据、文献综述、翻新市场和产品基础分析。目标竞争对手的市场分析可以从基于技术的分析到市场组合策略进行分析。我们可以按照您所需的格式和数据样式添加您需要的任意数量的竞争对手数据。我们的分析师团队还可以为您提供原始 Excel 文件数据透视表（事实手册）中的数据，或者可以帮助您根据报告中的数据集创建演示文稿。

中东和非洲炭疽病治疗市场 - 行业趋势和 2029 年预测

通过敏捷供应链咨询解决关税挑战

中东和非洲炭疽病治疗市场分析与洞察

中东和非洲炭疽病治疗市场动态

中东和非洲炭疽病治疗市场细分

炭疽病治疗市场区域分析/见解

竞争格局和炭疽病治疗市场份额分析

Get online access to the report on the World's First Market Intelligence Cloud

目录

表格列表

图片列表

研究方法

可定制

报告

市场洞察

支持

解决方案

中东和非洲炭疽病治疗市场 - 行业趋势和 2029 年预测

通过敏捷供应链咨询解决关税挑战

中东和非洲炭疽病治疗市场分析与洞察

中东和非洲炭疽病治疗市场动态

中东和非洲炭疽病治疗市场细分

炭疽病治疗市场区域分析/见解

竞争格局和炭疽病治疗市场份额分析

Get online access to the report on the World's First Market Intelligence Cloud

目录

表格列表

图片列表

研究方法

可定制

浏览相关页面